Koers Goodbody Health Canadian Securities Exchange
Aandelen
SWEL
CA3821591011
Farmaceutische producten
Omzet 2020 | 1,99 mln. 2,54 mln. 3,47 mln. 2,34 mln. | Omzet 2021 | 17,06 mln. 21,73 mln. 29,69 mln. 20,02 mln. | Marktkapitalisatie | 13,76 mln. 17,52 mln. 23,94 mln. 16,15 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -4 mln. -5,09 mln. -6,96 mln. -4,69 mln. | Nettowinst (verlies) 2021 | -2 mln. -2,55 mln. -3,48 mln. -2,35 mln. | EV/omzet 2020 | 5,41 x |
Nettoliquiditeiten 2020 | 1,37 mln. 1,75 mln. 2,39 mln. 1,61 mln. | Nettoliquiditeiten 2021 | 5,73 mln. 7,3 mln. 9,97 mln. 6,73 mln. | EV/omzet 2021 | 0,47 x |
K/w-verhouding 2020 |
-1,4
x | K/w-verhouding 2021 |
-5,64
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 70,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26-01-21 |
Geremy Thomas
FOU | Founder | 64 | 14-02-11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14-02-11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26-01-21 |
Anne Tew
SEC | Corporate Secretary | - | 01-11-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,65% | 6,04 mld. | |
-19,68% | 4,27 mld. | |
+4,49% | 3,28 mld. | |
-15,69% | 2,96 mld. | |
-5,64% | 2,43 mld. | |
+44,89% | 1,93 mld. | |
-12,71% | 1,59 mld. | |
-4,27% | 1,58 mld. | |
-14,86% | 1,5 mld. |